Teleo virtual therapy for kids: testing engagement and outcomes in clinical care
Official title: Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Run by Stanford University · NCT07155707 · Data updated 2026-11-12
We’re testing whether Teleo, a kid-focused virtual therapy platform, keeps young patients more engaged and improves anxiety and mood symptoms compared with standard video calls.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 14 Years |
| Sex | All |
| Enrollment | 156 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 2 sites (Monterey, California and 1 other locations) |
| Status | Recruiting |
| Started | June 24, 2026 |
| Main results expected | September 15, 2027 |
| Study ends | September 15, 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07155707 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking youths with mood or anxiety disorders starting psychotherapy at one of the study sites and meeting RCADS thresholds who can participate via telehealth.
✕Probably not a fit
Individuals with contraindications to telehealth or who do not respond to teletherapy may not experience additional benefit over standard care.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase II trial will compare engagement and clinical outcomes between Teleo, a tailored telehealth psychotherapy environment for youth, and standard videoconferencing. The study plans to enroll 156 families across two sites to see how each approach affects treatment attendance, clinician satisfaction, treatment duration, medication needs, and symptoms of anxiety and depression. Participants are children and adolescents with mood or anxiety disorders who can participate in English and are starting therapy at one of the study sites. Exclusion criteria include intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidality, substance use disorders, or conditions hindering telehealth engagement. The lead sponsor is Stanford University, with collaboration from NIMH and MainSquare Co. (Teleo).
Why it matters
Potential benefit: If Teleo improves engagement and clinical outcomes, participants may experience better symptom relief and smoother access to care.
How similar studies have gone: Previous studies in pediatric telepsychiatry suggest that tailored digital therapy environments can improve engagement and certain outcomes, but results vary by platform and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with a mood and/or anxiety disorder * Have proficiency to participate in psychotherapy in English * Scheduled to begin therapy at one of the study sites * RCADS score \> 65 Exclusion Criteria: \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Where it's running
-
Stanford University
Stanford, California, United States Recruiting -
Ohana Center for Child and Adolescent Behavioral Health
Monterey, California, United States Not yet recruiting
Study contacts
- Principal investigator: David S Hong, MD — Stanford University
- Study coordinator: Jesse A Barrera, BA
- Email: barreraj@stanford.edu
- Phone: 6193792399
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Unified Protocol for emotional disorders in prison groups
This study tests the Unified Protocol in group sessions to help inmates with anxiety, depression, and related mood issues.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
-
Using RxWell to Reduce Opioid Use After Knee or Hip Surgery
This study is testing whether a digital tool called RxWell can help people with mood disorders who are having knee or hip surgery reduce their opioid use and improve their mental health after the operation.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.